A new age in liquid biopsy research with highly accurate short-read sequencing

New, proprietary technology from PacBio delivers a 10 to 100-fold increase in accuracy over traditional short-read sequencing platforms. With enhanced sensitivity and reduced sequencing depth, PacBio short-read sequencing technology empowers cancer researchers to see what they haven’t been able to before.

In this webinar, learn about game-changing liquid biopsy research capabilities made possible by the Onso sequencing system and powered by proprietary sequencing by binding (SBB) chemistry.

Watch the recording to:

  • Understand SBB chemistry and how it enables Q40+ accuracy. 
  • Learn why sequencing accuracy is so important for liquid biopsy research. 
  • See how SBB can increase sensitivity and reduce the sequencing required for ctDNA detection.
  • Review new data coming off the Onso system.

Register to watch recording

By registering on this web page, you are consenting and agreeing to collection and use of your information by PacBio in accordance with its privacy policy 


Young Kim
Sr. Staff Product Manager, PacBio
Changing the game: sequencing by binding
Alex Sockell, PhD
Manager, Oncology & Cancer Research, PacBio
The next era in short-read sequencing for liquid biopsy 

Geoff Henno
Associate Director, Precision Health, PacBio
Host and moderator

Democratizing Genome Assembly and Annotation

Ted Kalbfleisch, Ph.D., Associate Professor, University of Kentucky

Molecular Genetic Applications Enabled by Platinum Quality Reference Genome Assemblies in Octoploid Strawberry

Mitchell Feldmann, Ph.D., Postdoctoral Fellow, University of California, Davis.